How to Buy Ironwood Pharmaceuticals Stock
Ironwood Pharmaceuticals Inc
Ironwood Pharmaceuticals, Inc. , a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products.
Ironwood Pharmaceuticals stock last closed at $0.93, down 0.85% from the previous day, and has decreased 87.97% in one year. It has underperformed other stocks in the Drug Manufacturers - Specialty & Generic industry by 0.3 percentage points. Ironwood Pharmaceuticals stock is currently +57.7% from its 52-week low of $0.59, and -88.97% from its 52-week high of $8.45.
At the moment, there are 161.81M shares of IRWD outstanding. The market cap of IRWD is $150.81M. In the last 24 hours, 1.5M IRWD shares were traded.
How to Buy Ironwood Pharmaceuticals Stock
Not sure how to invest in Ironwood Pharmaceuticals stock? Here's how.
- Decide where to buy Ironwood Pharmaceuticals stock: You need to pick an online brokerage, but don't worry - we've sifted through dozens of online stock brokerages and apps to help you decide where to buy Ironwood Pharmaceuticals stock.
- Sign up for your brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've selected.
- Fund your investment account: Pick your payment method and add your details.
- Research Ironwood Pharmaceuticals stock: The Ironwood Pharmaceuticals ticker symbol is IRWD. Is Ironwood Pharmaceuticals stock a good investment? Should you buy shares of IRWD? How do IRWD's underlying business fundamentals look? Do top analysts think Ironwood Pharmaceuticals is a good buy? Why has IRWD's stock price moved recently? (Hint: Our stock market research website can help you understand if IRWD is a good stock to buy).
- Make your IRWD trade: Decide if you will purchase IRWD shares at the current market price or use a limit order to purchase IRWD stock at a given price.
- Get notifications regarding your IRWD position: Create a watchlist to keep track of your investment in Ironwood Pharmaceuticals shares.
Step 1: Decide where to buy Ironwood Pharmaceuticals stock
You will need an online brokerage account in order to access the NASDAQ market and buy IRWD shares.
Our favorite brokerage: eToro
In our opinion, eToro is the best stock brokerage. Here's why:
- You can invest in stocks with zero commissions: Invest without paying trading commissions.
- Buy fractional shares: Even if you don't have the money to buy a full share, you can still buy the stock.
- Access to world financial markets: From Tech to Healthcare, New York to London (for US users, only US stocks are available) — you can fill your portfolio with stocks from the world's top stock exchanges.
- Social investing: eToro offers a community of more than 20 million users around the world. Talk to, learn from, and copy the unique crypto portfolios of top investors.
- Security: eToro is a regulated and licensed brokerage platform.
- Buy other financial assets: Such as ETFs and cryptos.
Get $10 towards your share purchase by opening an account with eToro now. This offer is only for US users.
Open eToro AccountStep 2: Sign up for your brokerage account
Now that you've selected your brokerage, you need to fill out some personal information so you are able to buy IRWD today.
How to Create a New Brokerage Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Enter your personal info to open a new trading account.
- Submit your information by pressing the "Create Account" button. Get started with eToro today
Step 3: Fund your investment account
Now that you have created your account on the best stock buying app, you can securely and quickly fund your account:
Check out the walkthrough below for more details depositing money into your brokerage account.
Step 4: Research Ironwood Pharmaceuticals stock
After you have identified the best place to buy Ironwood Pharmaceuticals stock, it's critical to evaluate their stock before you buy, so you can understand the risk and opportunity.
Ironwood Pharmaceuticals quick stats
Fundamentals of Ironwood Pharmaceuticals
WallStreetZen was built to help average investors perform more accurate fundamental analysis.
You can see all of the due diligence checks on IRWD's stock page.
Is IRWD stock overvalued?
You can use many financial metrics, analyses, models, and charts to gauge IRWD's true value.
Using relative valuations ratios:
- IRWD may be overvalued based on its P/E ratio of 93.2x, relative to Drug Manufacturers - Specialty & Generic industry P/E ratio of 21.23x
- IRWD may be undervalued based on its PEG ratio of 0.49x
You can access more valuation research on IRWD's stock here.
A quick look at IRWD Financials
Passed Health Checks:
- IRWD profit margin has gone up from -226.4% to 0.3% in the past year.
- There are more short-term assets than short-term liabilities on the IRWD balance sheet.
Failed Health Checks:
- Total IRWD debt is still negative.
- IRWD debt to equity ratio of -2.17 is negative.
- IRWD's operating cash flow of $103.55M allows it to safely service it's debt of $599.48M.
- There are more long-term liabilities than short-term assets on the IRWD balance sheet.
- IRWD earnings of $98.23M is not sufficient to cover its interest payments.
Is IRWD stock a Buy, Hold, or Sell, according to analysts?
Out of 5 Wall Street analysts who give recommendations on IRWD, the consensus analyst rating on IRWD is a Hold
It's important to note that analyst ratings are not recommendations, nor are they investment advice.
You can dive deeper into what analysts are saying on the Ironwood Pharmaceuticals stock forecast page.
IRWD Technicals
Is IRWD Making Money?
Last year, IRWD earnings were $880.00k. In the last 5 year, IRWD's earnings have grown by -41.01% per year. This was slower than the Drug Manufacturers - Specialty & Generic industry average of 5.89%.
Last year, IRWD revenue was $351.41M. During the last 5 year, IRWD's revenue has gone up by -3.89% per year. This was slower than the Drug Manufacturers - Specialty & Generic industry average of 7.88%.
Find out more about IRWD's earnings and revenue performance here.
Are IRWD insiders buying or selling the stock?
Over the past 12 months, executives and large shareholders at IRWD have sold more shares than they have bought.
Minardo John, Chief Legal Officer of IRWD, was the latest IRWD insider to sell. They sold $68,530.88 worth of IRWD shares on Feb 10, 2025.
Research more about who owns IRWD stock here.
Can I rely on IRWD as an income stream?
No, Ironwood Pharmaceuticals doesn't provide an income stream by paying out dividends.
What others are saying about IRWD
One of the major reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to find out what other investors have to say.
Step 5: Make your IRWD trade
You have two primary order types:
- Market order: A market order is an order to buy or sell a security at the best price on the market.
Market orders are generally sufficient. - Limit order: A limit order enables you to buy or sell a stock at a specific price (or better).
If you want to be certain you're buying or selling at an exact dollar amount limit, place a limit order.
Hit the Open button and eToro will execute the order.
If you need more help buying stocks on eToro, watch the how to video below:
Step 6: Get notifications regarding your IRWD position
Now that you own some IRWD shares, you'll want to keep up with your investment.
Start a watchlist to get alerted to the latest events about your IRWD stock.
IRWD Feed
How to Buy Stock in Ironwood Pharmaceuticals
To reiterate, here are the 6 steps for buying Ironwood Pharmaceuticals stock:
- Decide where to buy Ironwood Pharmaceuticals stock
- Sign up for your brokerage account
- Fund your investment account
- Research Ironwood Pharmaceuticals stock
- Make your IRWD trade
- Get notifications regarding your IRWD position
If you require a place to buy stocks, eToro is our recommended option.
Get Started with eToro TodayIf you want to watch your new investment in Ironwood Pharmaceuticals, click below.
Other Articles You Might Like
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.